Clinical Trial Update: Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating drug interactions between dapagliflozin and valsartan or simvastatin in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• SIMVASTATIN (SIMVASTATIN)
• VALSARTAN (Valsartan)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED